Principal Financial Group
MIRM icon

Principal Financial Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Principal Financial Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Buy
101,900
+44,531
+78% +$4.47M 0.01% 1311
2026
Q1 		$5.3M Buy
57,369
+25,710
+81% +$2.42M ﹤0.01% 1610
2025
Q4 		$2.5M Buy
31,659
+9,219
+41% +$662K ﹤0.01% 1803
2025
Q3 		$1.65M Sell
22,440
-8,980
-29% -$571K ﹤0.01% 1844
2025
Q2 		$1.6M Buy
+31,420
New +$1.4M ﹤0.01% 1832
2024
Q3 		– Sell
-7,001
Closed -$239K – 2340
2024
Q2 		$239K Sell
7,001
-1,326
-16% -$34.8K ﹤0.01% 2108
2024
Q1 		$209K Buy
8,327
+104
+1% +$2.86K ﹤0.01% 2166
2023
Q4 		$243K Sell
8,223
-88
-1% -$2.66K ﹤0.01% 2115
2023
Q3 		$263K Sell
8,311
-317
-4% -$8.68K ﹤0.01% 2096
2023
Q2 		$223K Buy
+8,628
New +$229K ﹤0.01% 2153
2022
Q3 		– Sell
-34,971
Closed -$681K – 2546
2022
Q2 		$681K Buy
+34,971
New +$825K ﹤0.01% 1990

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Principal Financial Group's MIRM Position: Q2 2026 in Review

Principal Financial Group increased its Mirum Pharmaceuticals (MIRM) stake by 78% in Q2 2026, buying an estimated $4.47M and bringing the position to 101,900 shares worth $11.9M. The position accounts for 0.01% of the portfolio, ranked #1311.

Principal Financial Group first reported a position in MIRM in Q2 2022 and has held it in 11 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Principal Financial Group held 101,900 shares of Mirum Pharmaceuticals worth $11.9M as of Q2 2026.
  • Principal Financial Group bought 44,531 Mirum Pharmaceuticals shares in Q2 2026, an estimated $4.47M.
  • Mirum Pharmaceuticals made up 0.01% of Principal Financial Group's portfolio in Q2 2026, its #1311 holding.
  • Principal Financial Group first reported a position in Mirum Pharmaceuticals in Q2 2022 and has held it in 11 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.